background
develop
protect
vaccin
canin
viscer
leishmaniasi
cvl
altern
approach
interrupt
domest
cycl
leishmania
infantum
given
import
sand
fli
salivari
protein
potent
immunogen
obligatorili
codeposit
transmiss
leishmania
parasit
inclus
antileishmania
vaccin
investig
last
decad
context
previous
immun
dog
vaccin
compos
l
braziliensi
antigen
plu
saponin
adjuv
sand
fli
salivari
gland
extract
lbsapsal
vaccin
vaccin
elicit
increas
antisaliva
antileishmania
igg
isotyp
higher
count
specif
circul
cell
high
product
method
investig
immunogen
protect
effect
lbsapsal
vaccin
intraderm
challeng
latelogphas
l
infantum
promastigot
presenc
sand
fli
saliva
lutzomyia
longipalpi
dog
follow
day
challeng
result
lbsapsal
vaccin
present
extens
antigen
divers
persist
humor
cellular
immun
respons
indic
resist
cvl
trigger
high
level
total
igg
subtyp
expans
circul
lymphocyt
leishmaniaspecif
reduct
splenic
parasit
load
conclus
result
encourag
studi
vaccin
strategi
address
leishmania
antigen
combin
protein
present
saliva
vector
dog
import
domest
reservoir
leishmania
infantum
protozoan
parasit
caus
viscer
leishmaniasi
vl
repres
major
sourc
contagion
vector
increas
risk
human
infect
treatment
infect
dog
effect
strategi
relaps
frequent
dog
quickli
becom
infecti
context
vaccin
would
import
tool
control
canin
viscer
leishmaniasi
cvl
would
also
dramat
decreas
infect
pressur
l
infantum
human
signific
effort
made
sever
group
develop
vaccin
cvl
given
wide
spectrum
antigen
cost
safeti
first
gener
vaccin
compos
crude
antigen
also
repres
excel
tool
immunoprophylaxi
phase
ii
clinic
trial
mayrink
et
al
demonstr
enhanc
lymphocyt
prolifer
signific
protect
experiment
infect
l
infantum
dog
receiv
ultrasounddisrupt
merthiol
promastigot
l
braziliensi
bacillu
calmeteguerin
bcg
strong
cellular
prolifer
respons
solubl
leishmania
antigen
also
report
dog
vaccin
autoclav
l
major
promastigot
plu
bcg
adjuv
moreov
doubleblind
random
efficaci
field
trial
singl
dose
vaccin
compos
alumprecipit
autoclav
l
major
vaccin
cvl
mix
bcg
shown
safe
decreas
incid
cvl
equival
efficaci
rate
last
decad
incorpor
salivari
protein
phlebotomin
wide
use
experiment
challeng
studi
seek
potenti
target
vaccin
develop
leishmania
infect
protein
even
part
vaccin
composit
adjuv
coadjuv
gome
et
al
show
hamster
immun
dna
plasmid
code
lutzomyia
longipalpi
protect
challeng
l
infantum
plu
lu
longipalpi
salivari
gland
sonic
collin
et
al
work
dog
immun
saliva
recombin
protein
lu
longipalpi
challeng
uninfect
infect
sandfli
observ
cellular
immun
respons
site
bite
character
lymphocyt
infiltr
express
result
suggest
use
lu
longipalpi
saliva
protein
could
good
strategi
develop
anticvl
vaccin
dog
context
previou
studi
dog
conduct
group
use
first
gener
vaccin
compos
l
braziliensi
antigen
plu
saponin
adjuv
sand
fli
salivari
gland
extract
sge
lbsapsal
vaccin
immun
elicit
increas
antisaliva
antileishmania
igg
isotyp
higher
count
circul
specif
high
product
immun
current
studi
includ
analysi
immunogen
parasitolog
investig
dog
immun
lbsapsal
vaccin
dog
evalu
day
challeng
intraderm
inocul
use
l
infantum
promastigot
plu
lu
longipalpi
sge
studi
protocol
approv
ethic
committe
use
experiment
anim
universidad
feder
de
ouro
preto
mina
gerai
brazil
close
coloni
lu
longipalpi
maintain
rel
humid
accord
publish
protocol
sand
fli
sge
prepar
use
method
cavalcant
et
al
acini
salivari
gland
mate
nonbloodf
femal
sand
fli
dissect
unbuff
salin
broken
sonic
centrifug
g
min
supernat
collect
store
prior
use
studi
use
lbsapsal
vaccin
previous
describ
giunchetti
et
al
twenti
male
femal
mongrel
dog
born
rear
kennel
anim
scienc
center
universidad
feder
de
ouro
preto
ouro
preto
mina
gerai
brazil
dog
treat
month
age
anthelmint
vaccin
rabi
tecpar
curitibapr
brazil
canin
distemp
type
adenoviru
coronaviru
parainfluenza
parvoviru
leptospira
htlp
pfizer
anim
health
new
york
ny
usa
absenc
specif
antileishmania
antibodi
confirm
indirect
fluoresc
immunoassay
enzymelink
immunosorb
assay
elisa
test
ouro
preto
citi
consid
nonendem
area
viscer
leishmaniasi
brazil
besid
neg
serolog
addit
effect
approach
perform
aim
rule
leishmania
infect
spray
kennel
ufop
pyrethroid
insecticid
protect
extens
kennel
appropri
secur
stainless
steel
wire
mesh
block
access
phlebotomin
begin
experi
dog
approxim
age
day
similar
weight
kilogram
randomli
chosen
set
approxim
number
male
femal
divid
four
experiment
group
control
group
c
n
receiv
ml
steril
salin
ii
sal
group
n
receiv
sge
prepar
five
acini
salivari
gland
lu
longipalpi
ml
steril
salin
iii
lbsal
group
n
receiv
l
braziliensi
promastigot
protein
plu
sge
ml
steril
salin
iv
lbsapsal
group
n
receiv
l
braziliensi
promastigot
protein
plu
mg
saponin
togeth
sge
ml
steril
salin
group
receiv
three
subcutan
inject
right
flank
interv
week
three
half
month
day
last
vaccin
dose
dog
challeng
via
intraderm
inject
right
ear
latelogphas
l
infantum
promastigot
plu
sge
obtain
two
acini
lu
longipalpi
salivari
gland
dog
follow
day
challeng
evalu
humor
cellular
immun
respons
perform
challeng
tbc
ie
day
experiment
challeng
day
challeng
dac
dog
euthan
dac
spleen
collect
evalu
parasit
load
peripher
blood
ml
collect
jugular
vein
dog
transfer
tube
contain
edta
anticoagul
absolut
count
lymphocyt
sampl
obtain
use
vet
auto
hematolog
analyz
mindray
china
blood
sampl
store
room
temperatur
h
prior
process
humor
immun
respons
evalu
use
solubl
lysat
l
infantum
antigen
slia
accord
convent
enzymelink
immunosorb
assay
elisa
previous
describ
rei
et
al
giunchetti
et
al
briefli
slia
coat
onto
micropl
nalg
nunc
intl
rochest
ny
usa
concentr
serum
sampl
ad
dilut
well
wash
peroxidaseconjug
goat
antidog
sheep
antidog
igg
bethyl
laboratori
inc
montgomeri
tx
usa
ad
dilut
respect
well
wash
substrat
chromogen
ophenylenediamin
sigmaaldrich
co
st
loui
mo
usa
ad
absorb
read
nm
mcc
labsystem
helsinki
finland
automat
micropl
reader
vitro
evalu
peripher
blood
mononuclear
cell
pbmc
isol
ml
heparinis
blood
ml
ficollhypaqu
densiti
gradient
sigma
chemic
co
centrifug
g
min
room
temperatur
pbmc
resuspend
gibco
medium
homogen
wash
twice
rpmi
centrifug
g
min
room
temperatur
homogen
resuspend
rpmi
cell
ml
briefli
mitogen
stimulu
assay
aliquot
pbmc
cellswel
ad
triplic
well
togeth
phytohemagglutinin
sigmaaldrich
chemi
gmbh
taufkirchen
germani
incub
carri
humidifi
co
atmospher
day
mitogenicstimul
cultur
day
antigenicstimul
cultur
investig
immunophenotyp
featur
pbmc
cultur
flatbottom
tissu
cultur
plate
costar
cambridg
usa
contain
supplement
rpmi
mediumwel
fifti
microlit
pbmc
cellswel
ad
triplic
well
togeth
vaccin
solubl
antigen
vsa
slca
incub
carri
humidifi
co
atmospher
day
pbmc
remov
immunophenotyp
accord
giunchetti
et
al
unlabel
canin
monoclon
antibodi
mab
clone
clone
clone
purchas
serotec
usa
use
indirect
immunofluoresc
procedur
pool
normal
rat
serum
dilut
employ
isotyp
control
fluorescein
isothiocyan
fitc
label
igg
sheep
antirat
polyclon
antibodi
use
secondari
antibodi
briefli
micropl
assay
immunophenotyp
canin
whole
blood
leukocyt
fresh
blood
sampl
pbmc
obtain
vitro
stimul
carri
accord
method
previous
describ
giunchetti
et
al
result
express
percentag
posit
cell
within
gate
lymphocyt
cell
surfac
marker
present
bimod
distribut
total
genom
dna
extract
approxim
milligram
spleen
use
genom
dna
purif
kit
madison
wi
usa
follow
manufactur
recommend
quantifi
parasit
burden
primer
describ
bretagn
et
al
amplifi
fragment
singl
copi
number
gene
dna
polymeras
l
infantum
genbank
access
number
use
pcr
carri
final
volum
contain
nm
forward
revers
primer
green
reaction
master
mix
appli
biosystem
usa
templat
dna
pcr
condit
follow
initi
denatur
step
min
follow
cycl
denatur
anneal
extens
min
standard
curv
prepar
run
use
known
quantiti
plasmid
madison
wi
usa
contain
insert
interest
verifi
integr
sampl
procedur
carri
gapdh
gene
fragment
genbank
access
number
reaction
process
analyz
abi
prism
detect
system
appli
biosystem
usa
result
express
number
amastigot
per
milligram
spleen
statist
analys
perform
use
prism
softwar
packag
prism
softwar
irvin
ca
usa
normal
data
detect
use
kolmogorovsmirnoff
test
oneway
analysi
varianc
tukey
posttest
use
determin
differ
group
case
differ
consid
signific
p
valu
lbsapsal
elicit
last
product
antil
infantum
immunoglobulin
isotyp
igg
l
infantum
experiment
challeng
observ
lbsapsal
group
compar
c
sal
lbsal
group
figur
also
lbsapsal
group
elicit
higher
level
p
tbc
dac
compar
group
c
sal
lbsal
moreov
lbsapsal
group
show
higher
level
p
dac
compar
c
sal
group
figur
higher
level
p
antileishmania
observ
lbsapsal
group
tbc
dac
compar
group
c
sal
lbsal
figur
analysi
demonstr
ratio
lower
p
lbsapsal
group
compar
c
tbc
dac
sal
tbc
dac
lbsal
tbc
group
figur
order
evalu
cellular
immunophenotyp
profil
enumer
frequenc
lymphocyt
major
subpopul
figur
result
reveal
increas
p
number
circul
lymphocyt
dog
vaccin
lbsapsal
group
dac
compar
c
sal
group
dac
compar
c
sal
lbsal
group
figur
analys
data
show
increas
p
circul
lymphocyt
lbsapsal
group
compar
c
sal
group
dac
c
sal
lbsal
group
dac
figur
way
higher
p
tcell
count
observ
dog
vaccin
lbsapsal
dac
compar
c
sal
lbsal
group
dac
compar
c
sal
group
dac
compar
sal
group
dac
comparison
group
figur
analysi
demonstr
ratio
higher
p
lbsapsal
group
compar
c
group
hand
dac
ratio
lower
p
lbsapsal
group
comparison
c
group
figur
explor
vitro
cell
prolifer
pbmc
use
two
differ
antigen
stimuli
vsa
l
braziliensi
order
evalu
memori
lymphoprolif
immun
respons
antigen
vaccin
compon
slia
investig
possibl
lymphoprolif
homolog
etiolog
agent
vl
l
infantum
figur
compar
analysi
differ
treatment
group
show
significantli
augment
p
stimul
index
dac
lbsapsal
dog
compar
c
dac
group
vsa
stimuli
figur
addit
lbsapsal
group
exhibit
higher
p
lymphoprolif
index
dac
compar
c
lbsal
dog
slia
stimuli
figur
higher
frequenc
lymphocyt
antigenstimul
cultur
relat
major
phenotyp
chang
lbsapsalvaccin
dog
l
infantum
experiment
challeng
order
evalu
whether
phenotyp
profil
pbmc
vaccinatedchalleng
dog
influenc
vsa
slia
stimul
well
character
cell
conduct
analysi
phenotyp
featur
pbmc
vaccinatedchalleng
dog
figur
presenc
vsa
figur
signific
increas
p
stimul
cellnonstimul
cell
ratio
cell
observ
lbsapsal
dog
compar
lbsal
group
dac
evalu
slia
stimulu
figur
signific
increas
p
ratio
cell
observ
lbsapsal
dog
dac
compar
dac
addit
lbsapsal
group
show
higher
p
ratio
lymphocyt
compar
c
dog
dac
contrast
lbsapsal
group
display
signific
decreas
p
tcell
ratio
compar
sal
dog
dac
main
parasitolog
featur
present
anim
summar
figur
shown
figur
lower
p
number
amastigot
observ
lbsapsal
lbsal
group
compar
c
dog
data
associ
parasit
burden
reduct
lbsal
dog
lbsapsal
group
compar
c
anim
result
indic
high
protect
potenti
lbsapsal
vaccin
even
extend
period
challeng
dac
addit
sand
fli
saliva
extract
vectorbas
vaccin
enhanc
abil
host
control
block
parasit
infect
sens
studi
dog
evalu
immunogen
efficaci
vaccin
compos
l
braziliensi
crude
antigen
saponin
adjuv
sand
fli
salivari
gland
extract
lbsapsal
vaccin
day
intraderm
inocul
use
l
infantum
sge
lu
longipalpi
previou
studi
group
demonstr
immun
lbsapsal
vaccin
induc
high
level
total
igg
antileishmania
antibodi
interestingli
present
studi
demonstr
signific
increas
immunoglobulin
day
experiment
challeng
propos
serum
reactiv
observ
vaccin
dog
indic
antigen
recognit
l
infantum
suggest
establish
immunogen
event
howev
still
clear
subclass
immunoglobulin
would
associ
cvl
resist
pattern
increas
subclass
appear
character
mix
profil
immun
respons
previous
describ
dog
vaccin
crude
antigen
moreov
controversi
concern
associ
profil
relat
resist
suscept
infect
cvl
immunophenotyp
canin
leukocyt
flow
cytometri
use
attempt
establish
pattern
associ
cellular
profil
link
resist
suscept
infect
l
infantum
beyond
immunogen
profil
anticvl
vaccin
trial
result
reveal
increas
number
circul
lymphocyt
dog
vaccin
lbsal
lbsapsal
increas
associ
high
level
tand
tlymphocyt
subpopul
interestingli
lbsapsal
vaccin
induc
persist
increas
lymphocyt
throughout
period
challeng
immunophenotyp
cvl
studi
increas
lymphocyt
subset
lymphocyt
report
relat
profil
associ
possibl
resist
infect
l
infantum
brazilian
endem
area
vaccin
dog
use
leishmun
associ
increas
frequenc
lymphocyt
absenc
clinic
sign
month
immun
increas
circul
lymphocyt
dog
vaccin
cvl
consid
import
biomark
resist
infect
leishmania
thu
expans
lymphocyt
sustain
increas
subset
observ
lbsapsal
vaccin
dog
seem
reflect
attempt
immun
system
erad
parasit
intraderm
experiment
challeng
larg
antigen
repertoir
composit
lbsapsal
vaccin
probabl
induc
respons
memori
lymphocyt
expand
peripher
blood
induc
transient
increas
lymphocyt
due
exposur
parasit
attempt
dog
immun
system
control
possibl
increas
spread
l
infantum
parasit
organ
determin
whether
lbsapsal
vaccin
would
abl
activ
pbmc
vitro
antigen
stimul
vsa
slia
measur
stimul
index
dac
cell
deriv
immun
dog
pbmc
sal
lbsapsal
group
abl
recogn
respond
vsa
show
increas
stimul
index
level
compar
c
group
stimul
observ
pbmc
salvaccin
dog
indic
nonspecif
stimul
use
sge
experiment
challeng
could
stimul
immun
cell
occasion
oscil
occur
anim
moreov
stimul
pbmc
slia
increas
stimul
index
observ
lbsapsal
group
dac
compar
c
dog
interestingli
studi
dog
immun
bival
vaccin
compos
crude
antigen
leishmania
strain
l
amazonensi
l
braziliensi
associ
bcg
adjuv
show
greater
lymphoprolif
capac
respons
stimul
antigen
l
infantum
furthermor
abil
stimul
lymphoprolif
activ
use
antigen
leishmania
associ
immun
profil
relat
resist
cvl
support
hypothesi
lbsapsal
vaccin
induc
specif
immun
respons
caus
agent
cvl
analysi
seek
identifi
phenotyp
profil
pbmc
vitro
stimul
vsa
slia
show
increas
stimul
ratio
lymphocyt
lbsal
lbsapsal
group
presenc
slia
compar
c
group
fact
result
reflect
expans
circul
lymphocyt
observ
ex
vivo
analysi
lbsapsal
group
addit
rei
et
al
describ
high
number
lymphocyt
spleen
asymptomat
dog
presenc
leishmania
antigen
compar
symptomat
dog
indic
import
cell
control
l
infantum
infect
dog
sens
human
dog
asymptomat
infect
link
higher
leishmaniaspecif
lymphocyt
data
vitro
immunophenotyp
profil
demonstr
greater
abil
lbsapsal
vaccin
control
parasit
dog
reflect
improv
control
tissu
parasit
observ
vaccin
dog
thu
lbsapsalvaccin
dog
show
leishmaniaspecif
memori
cell
consist
abil
elimin
parasit
intraderm
experiment
challeng
context
differ
experiment
natur
challeng
number
parasit
life
cycl
stage
amastigot
promastigot
rout
infect
presenc
absenc
vector
saliva
import
variabl
must
taken
account
experiment
challeng
canin
model
experiment
challeng
use
intraven
rout
high
number
parasit
promastigot
seem
effici
challeng
model
howev
type
challeng
hide
real
experiment
vaccin
efficaci
suppress
protect
respons
could
present
vaccin
dog
thu
experiment
model
infect
close
resembl
leishmania
natur
transmiss
increasingli
recommend
desir
mani
investig
howev
use
infect
sandfli
easi
remain
obstacl
dog
model
work
use
sge
associ
experiment
challeng
attempt
mimic
sand
fli
feed
blood
inocul
anim
saliva
leishmania
promastigot
howev
result
show
dog
remain
asymptomat
throughout
followup
dac
indic
use
sge
suffici
replic
bite
environ
enhanc
experiment
infect
studi
select
spleen
target
tissu
detect
parasit
natur
one
major
site
parasit
realtim
pcr
techniqu
use
sever
author
order
diagnos
screen
evolut
vl
quantifi
parasit
burden
offer
high
sensit
accuraci
reproduc
work
appli
realtim
pcr
techniqu
quantifi
number
amastigot
per
milligram
spleen
interestingli
found
lbsal
group
lbsapsal
dog
higher
proport
parasit
reduct
compar
control
anim
reduct
parasit
load
may
associ
immun
respons
induc
salivari
compon
present
vaccin
studi
show
lu
longipalpi
salivari
protein
induc
immun
respons
associ
protect
dog
furthermor
hamster
model
salivari
protein
sand
fli
vector
protect
fatal
outcom
viscer
leishmaniasi
thu
protect
obtain
present
studi
confirm
capac
prototyp
vaccin
lbsapsal
limit
parasit
replic
even
long
challeng
day
present
studi
lbsapsal
vaccin
offer
great
antigen
divers
persist
humor
cellular
immun
respons
elicit
indic
resist
phenotyp
cvl
induct
high
level
total
igg
expans
circul
